Archive for July, 2023

Recent Rosacea Blog Posts

DFD-29 from Journey Medical may best out Oracea

Journey Medical Corporation are readying to release their Phase 3 clinical trial data for DFD-29, their delayed release 40mg minocycline treatment for rosacea. Targeted as a competitor to Galderma’s successful doxycycline based Oracea, the yet to be named DFD-29 is expected to release clinical data that will demonstrate superior treatment results. According to Journey Medical’s […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.